Assembly of Human Hemoglobin
STUDIES WITH ESCHERICHIA COLI-EXPRESSED alpha -GLOBIN*

(Received for publication, July 10, 1996, and in revised form, November 13, 1996)

Maria Teresa Sanna Dagger §, Anna Razynska Dagger , Michael Karavitis Dagger , Aditya P. Koley , Fred K. Friedman , Irina M. Russu par , William S. Brinigar ** and Clara Fronticelli Dagger Dagger Dagger

From the Dagger  Department of Biochemistry and Molecular Biology, Medical School, University of Maryland, Baltimore, Maryland 21201, the  Laboratory of Molecular Carcinogenesis, NCI, National Institutes of Health, Bethesda, Maryland, 20892, the par  Department of Molecular Biology and Biochemistry, Hall-Atwater-Shanklin Laboratories, Wesleyan University, Middletown, Connecticut 06459, and the ** Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
FOOTNOTES
Acknowledgements
REFERENCES


ABSTRACT

The alpha -globin of human hemoglobin was expressed in Escherichia coli and was refolded with heme in the presence and in the absence of native beta -chains. The functional and structural properties of the expressed alpha -chains were assessed in the isolated state and after assembly into a functional hemoglobin tetramer. The recombinant and native hemoglobins were essentially identical on the basis of sensitivity to effectors (Cl- and 2,3-diphosphoglycerate), Bohr effect, CO binding kinetics, dimer-tetramer association constants, circular dichroism spectra of the heme region, and nuclear magnetic resonance of the residues in the alpha 1beta 1 and alpha 1beta 2 interfaces. However, the nuclear magnetic resonance revealed subtle differences in the heme region of the expressed alpha -chain, and the recombinant human normal adult hemoglobin (HbA) exhibited a slightly decreased cooperativity relative to native HbA. These results indicate that subtle conformational changes in the heme pocket can alter hemoglobin cooperativity in the absence of modifications of quaternary interface contacts or protein dynamics. In addition to incorporation into a HbA tetramer, the alpha -globin refolds and incorporates heme in the absence of the partner beta -chain. Although the CO binding kinetics of recombinant alpha -chains were the same as that of native alpha -chains, the ellipticity of the Soret circular dichroism spectrum was decreased and CO binding kinetics revealed an additional faster component. These results show that recombinant alpha -chain assumes alternating conformations in the absence of beta -chain and indicate that the isolated alpha -chain exhibits a higher degree of conformational flexibility than the alpha -chain incorporated into the hemoglobin tetramer. These findings demonstrate the utility of the expressed alpha -globin as a tool for elucidating the role of this chain in hemoglobin structure-function relationships.


INTRODUCTION

The basis of cooperative oxygen binding by human hemoglobin is an old problem that is being elucidated with the aid of modern technologies. Of particular importance is the elucidation of the properties of alpha - and beta -chains, both in the isolated state and incorporated into the hemoglobin tetramer. Such studies should provide fine details on the linkage between tertiary and quaternary structure that forms the basis of cooperative oxygen binding. The recent development of hemoglobin expression systems offers great promise for facilitating the study of such structure-function relationships. This approach has been particularly useful for investigating the physicochemical properties of hemoglobin and myoglobin and has been employed in the development of hemoglobin variants with properties suitable for clinical use as red cell substitutes (1).

Although Escherichia coli expression systems for HbA1 have been developed, the product exhibits structural and functional modifications relative to native HbA (2-4). Alternatively, tetrameric hemoglobins in which only the alpha - or beta -subunits are recombinant (alpha rHbA and beta rHbA) can be obtained by in vitro refolding of the expressed globin. beta -Globin has thus been expressed (5, 6) and refolded in the presence of native alpha -chains to yield recombinant hemoglobin whose conformational and functional properties resemble those of natural HbA (5, 6). In contrast, development of an analogous alpha -globin expression system was not as successful (7), although it is highly desirable as a tool for elucidating the tetrameric assembly and cooperativity of HbA.

In this paper we report the construction of a system for the synthesis of high levels of an alpha -globin fusion protein in E. coli. The conformational properties of the isolated chain are presented along with the functional and conformational characterization of reconstituted HbA tetramer following refolding of the expressed alpha -globin with heme in the presence of native beta -chains. Spectral measurements and oxygen binding of these proteins reveal new insights into the linkage between the conformation of the heme pocket, ligand access channel, and quaternary interactions.


MATERIALS AND METHODS

Plasmid Construction

The alpha -globin expression plasmid pNFalpha is structurally analogous to pJKO5, from which beta -globin has been routinely produced as a fusion protein, and comprises 83 residues of a flu virus protein, NS1, a Factor X recognition sequence followed by beta -globin. The construction of pNFalpha is similar to that of pJKO5 (6). Human alpha -globin cDNA was provided by B. G. Forget (Yale University) as a 700-base pair PstI insert in pKT218 (8). In an initial effort to express alpha -globin in E. coli, the 700-base pair PstI fragment was inserted into the PstI site of pKK-233-2 (Pharmacia Biotech Inc.), and the short region between the NcoI sites at the initiation ATG site in the globin gene was subsequently removed by digestion with NcoI followed by religation. The resulting plasmid, pBalpha 2, in JM101 induced with isopropyl-1-thio-beta -D-galactopyranoside was found to produce very low levels of alpha -globin. Although unsatisfactory as an expression system, the 750-base pair NcoI to XmnI fragment from this plasmid was used as a source of the alpha -globin gene for the construction of pNFalpha . pNFalpha was constructed in two steps. The initial construct, pNalpha , was formed by inserting the NcoI to XmnI fragment from pBalpha 2 into pJKO4 (6), from which the beta -globin gene had been removed by digestion with NcoI and EcoRV. (Note that both EcoRV and XmnI produce blunt ended DNA.) pJKO4 codes for a fusion protein composed of 81 residues of NS1 followed by beta -globin but does not have an intervening Factor X recognition sequence. pNalpha in E. coli strain AR120 (9), induced with nalidixic acid, produced high levels of the fusion protein NS1-alpha -globin (data not shown). A Factor X recognition sequence was inserted between the NS1 segment and alpha -globin by first digesting pNalpha with NcoI and making the DNA blunt ended with mung bean nuclease. Subsequent digestion with BglII removed the NS1 portion of the fused gene. This segment was replaced by the BglII to StuI fragment from pJKO1 (6), which contains the same NS1 portion followed by a Factor X recognition sequence. The resulting plasmid, pNFalpha , is structurally identical to pJKO5 except that alpha -globin cDNA replaces the beta -globin cDNA of pJKO5. This plasmid in strain AR120, induced with nalidixic acid, yielded large amounts of the NS1-FX-alpha -globin fusion protein as the principal component of the insoluble inclusion bodies.

Expression and Purification of the alpha -Globin

Growth, expression, and purification of the fusion protein followed a previously described protocol (6). Enzymatic cleavage was monitored by reverse phase HPLC using a Vydac C4 column. The solvents were: A, 20% CH3CN, 0.1% trifluoroacetic acid; and B, 60% CH3CN, 0.1% trifluoroacetic acid. The gradient was 44% B to 75% B over 120 min. Peaks were identified by eight cycles of Edman sequencing.

Reconstitution of alpha rHbA

Upon cleavage with Factor X, the alpha -globin was recovered as a precipitate, dissolved in a minimum volume of cold 0.1 M NaOH, and diluted to 2 mg/ml (A280 = 1.0 is taken as 1 mg/ml) with 0.04 M borate buffer, pH 9.0, 0.002 M EDTA. In order to solubilize the aggregates, the solution was deoxygenated by stirring under a constant stream of N2 followed by addition of dithiothreitol to a final concentration of 0.001 M. After 24 h at 4 °C the protein was reconstituted with cyanoheme and native beta -chains, prepared from carboxy-HbA by reaction with p-mercuribenzoate (10). p-Mercuribenzoate was removed from the isolated beta -chains as described by Geraci and Li (11). After 1 week the protein was concentrated and the heme converted to the CO derivative by addition of sodium dithionite under a stream of CO. The hemoglobin was purified on an affinity column of immobilized hemoglobin (12, 13). The collected fractions were analyzed on paragon gel electrophoresis (Beckman Instruments).

Refolding with Heme of Isolated alpha r

The alpha -globin was purified and reconstituted with cyanoheme as described. After 1 week at 4 °C the protein was concentrated and the heme converted to the CO form followed by dialysis against 0.001 M NaCl saturated with CO. The alpha r were purified by preparative isoelectrofocusing (Bio-Rad) according to the manufacturer's instructions. The pH range of the ampholyte was 3-10. Screening of the fractions was carried out on paragon electrophoresis (Beckman). The ampholyte was removed by repetitive washing with water using a Centriprep concentrator (Amicon).

Peptide Analysis

The natural and recombinant alpha -globins were isolated from the respective hemoglobin using reverse phase HPLC and a Vydac C4 column (14). Prior to tryptic digestion, the isolated alpha -globins were S-pyridylethylated and desalted (15). TPCK-treated trypsin (Sigma) was added to a ratio of 1:50 (w/w) and the solution let stand at room temperature for 20 h. The resulting clear solution was then injected into a 4.6 × 250 mm Vydac C18 column previously equilibrated with Buffer A (0.1% trifluoroacetic acid). The peptides were eluted using a gradient of 0-50% Buffer B (0.1% trifluoroacetic acid in 9:1 (v/v) CH3CN:H2O) over 60 min. The absorbance was monitored at 220 nm. Sequences were determined using a Hewlett-Packard model G1005A protein sequencing system following the procedures standardized by the manufacturer.

Oxygen Equilibrium Curves

Oxygen equilibrium measurements were performed using the thin layer dilution technique of Dolman and Gill (16) with an Aviv 14DS spectrophotometer. In this technique the oxyhemoglobin is deoxygenated by stepwise dilution of the equilibrating gas with constant volumes of N2. Formation of methemoglobin as judged by spectral deconvolution of the initial and final spectra was less than 10%. Protein concentration was 1.5-2.0 mM in heme in 0.05 M HEPES buffer at 25 °C. The experimental data were fitted to the Adair equation (17) using an iterative procedure incorporating the Marquardt algorithm,
<FR><NU>Y</NU><DE>4</DE></FR>=<FR><NU>&bgr;<SUB>1</SUB>p<UP>O</UP><SUB>2</SUB>+2&bgr;<SUB>2</SUB>p<UP>O</UP><SUB>2</SUB><SUP>2</SUP>+3&bgr;<SUB>3</SUB>p<UP>O</UP><SUB>2</SUB><SUP>3</SUP>+4&bgr;<SUB>4</SUB>p<UP>O</UP><SUP>4</SUP></NU><DE>1+&bgr;<SUB>1</SUB>p<UP>O</UP><SUB>2</SUB>+&bgr;<SUB>2</SUB>p<UP>O</UP><SUB>2</SUB><SUP>2</SUP>+&bgr;<SUB>3</SUB>p<UP>O</UP><SUB>2</SUB><SUP>3</SUP>+&bgr;<SUB>4</SUB>p<UP>O</UP><SUB>2</SUB><SUP>4</SUP></DE></FR> (Eq. 1)
where Y is the fractional saturation with O2, pO2 is the partial pressure of oxygen in millimeters of mercury, and beta i represents the overall Adair constants related to the intrinsic statistical affinity constant Ki of the subsequent steps of oxygenation by beta i = Pi iKi. The value of the median ligand activity, Pm, was determinated using the relation Pm = beta 4-0.25 (18).

CO Binding Kinetics

Flash photolysis was carried out on solutions containing 5 µM heme and 50 µM CO at 23 °C in 0.1 M Bis-Tris (pH 7.0) containing 0.1 M KCl. Approximately 0.5 mg of sodium dithionite was added to reduce any ferric heme to the ferrous state. The instrumentation and experimental details for laser flash photolysis were essentially as described previously (19). A pulse (0.6 µs) from a dye laser disrupted the photolabile heme Fe-CO bond, and the recombination of CO with the heme protein was then monitored by following the absorbance change at 436 nm. Data were transmitted to a microcomputer for processing and analysis.

Standard multiexponential analysis of the kinetic data was performed according to,
&Dgr;A<SUB>t</SUB>=<LIM><OP>∑</OP><LL>i<UP>=</UP>1</LL><UL>n</UL></LIM> a<SUB>i</SUB>e<SUP>(<UP>−</UP>k<SUB>i</SUB>t)</SUP> (Eq. 2)
where Delta At is the total absorbance change observed at time t, ai is the absorbance change for component i at t = 0, ki is the observed pseudo-first order rate constant for component i, and n is the number of independent components. Least square analysis was performed with RS/1 software (BBN Software Products, Cambridge, MA) on a Dell 450/ME microcomputer. Statistical significance (p < 0.05) was evaluated using Student's t test assuming equal variances.

Circular Dichroism

The CD spectra of the carboxyl derivatives were recorded in 0.05 M phosphate buffer at pH 7.0 using an Aviv CD 60 spectropolarimeter. Before recording the spectra hemoglobin was treated with dithionite under an atmosphere of CO and rapidly filtered through Sephadex G-25 resin. The optical spectra were deconvolved to verify that the heme was present only in the carboxyl form and to determine the exact protein concentration. The CD spectra, which are the average of three scans, were recorded every 0.3 nm using a bandwidth of 0.5 nm and a time constant of 1 s in a cuvette of 0.5 cm path length. Protein concentration was 0.2 mg/ml.

NMR Measurements

The NMR experiments were carried out on a VXR-400/54 spectrometer operating at 9.4 tesla. All NMR spectra reported here were obtained at 29 °C using the jump-and-return pulse sequence 90°(Phi )-tau -90°(-Phi ) (20). The delay tau  was adjusted for each experiment such that maximum excitation was obtained for the spectral region of interest. The relaxation delay between successive transients was 2.5 s. The proton chemical shifts are referenced to 2,2-dimethyl-2-silapentane-5-sulfonate.2

The samples of native HbA and alpha rHbA used for the NMR measurements were in 0.1 M Bis-Tris buffer, pH 6.85, in 90% H2O, 10% D2O. Hemoglobin concentration was between 7 and 9%, and methemoglobin content was 5% or less.


RESULTS

Protein Expression, Digestion, and Refolding

Fig. 1 shows SDS-polyacrylamide gel electrophoresis of the total cell proteins before and after induction as well as the detergent-insoluble fusion protein. This figure illustrates the high expression level of NS1-FX-alpha -globin and shows that treatment of the insoluble fraction with detergent eliminates a large part of the contaminant proteins.


Fig. 1. SDS-polyacrylamide gel electrophoresis of NS1-FX-beta -globin expression and purification. Before nalidixic acid induction (lane 1); 18 h after nalidixic acid induction (lane 2); fusion protein from detergent purification (lane 3); and marker proteins (45, 34, 24, 18.4, 14.3, 2.5 kDa, from top) (lane 4).
[View Larger Version of this Image (60K GIF file)]


The procedures for purification, cleavage, and reconstitution of the tetrameric hemoglobin were essentially the same as those used for beta rHbA (6). The pH values of the various reactions were increased due to the higher isoelectric point of the alpha -globin, which renders it less soluble than beta -globin at pH 8.5. The yield of alpha rHbA was 15-20 mg/liter of cell culture. Cleavage of the fusion protein with Factor Xa was followed by reverse phase HPLC. Fig. 2A shows the elution pattern of the detergent-purified fusion protein, and Fig. 2B shows the elution pattern of the fusion protein following 20 h of digestion with Factor Xa. The major peak corresponds to alpha -globin with the correct amino-terminal end, whereas the smaller peak is a product of overdigestion, which occurs at Argalpha 31(B12).


Fig. 2. Reverse phase electrophoresis on a Vydac C4 column of detergent-purified fusion protein NS1-FX-alpha -globin (A) and after 20 h of digestion with Factor X (B). The smaller peak at 60 m is given by alpha -globin digested at arginine 31. Buffers were 20% CH3CN, 0.1% trifluoroacetic acid (Buffer A) and 60% CH3CN, 0.1% trifluoroacetic acid (Buffer B). The gradient employed was 44% B to 75% B over 120 min.
[View Larger Version of this Image (11K GIF file)]


Peptide Maps of alpha -Chain from Normal Human HbA and ralpha HbA

Fig. 3, A and B, shows the tryptic peptide patterns obtained from normal and recombinant alpha -globins, respectively. The numbers above the peaks correspond to the tryptic fragments of the alpha -chain as listed in Table I. The HPLC profiles of tryptic digestion of the two alpha -globins are identical. Furthermore, five cycles of Edman sequential degradation on intact alpha -globins isolated from natural and recombinant HbA gave comparable yields of the expected 5 residues at the amino terminus. Sequence analysis of the peak eluting at 22 min identified an unresolved mixture of fragments 1 (residues 1-7) and 3 (residues 12-16). The peak eluting at 24 min contains fragment 1+2, a partial cleavage product (residues 1-11). The difference between peaks 12 and 13 eluting at 52 and 54 min is 1 Lys residue located at position alpha 61(E10).


Fig. 3. Tryptic peptide maps of native alpha -globin (A) and recombinant alpha -globin (B). The numbers above the peaks correspond to the tryptic fragments listed in Table I. The alpha -globins were isolated by HPLC, S-pyridylethylated, and digested with TPCK-treated trypsin. Chromatography was performed on a Vydac C18 column as described under "Materials and Methods."
[View Larger Version of this Image (13K GIF file)]


Table I.

Tryptic fragments of alpha -globins from native HbA and alpha rHbA


Fragment Residues Sequence

1 1-7 VLSPADK
2 8-11 TNVK
3 12-16 AAWGK
4 17-31 VGAHAGEYGAEALER
5 32-40 MFLSFPTTK
6 41-56 TYFPHFDLSHGSAQVK
7 57-60 GHGK
8 61 K
9 62-90 VADALTNAVAHVDDMPNALSALSDLHAHK
10 91-92 LR
11 93-99 VDPVNFK
12 100-127 LLSHCLLVTIAAHLPAEFTPAVHASLDK
13 128-139 FLASVSTVLTSK
14 140-141 YR

Circular Dichroism

-The spectrum in the Soret region is sensitive to the interaction of the heme with the surrounding aromatic residues (21). Fig. 4A shows the CD spectra of the carboxyl derivatives of HbA and alpha rHbA. Although these exhibit the same ellipticity at the peaks of their spectra, small differences are evident at lower wavelengths. Fig. 4B shows the CD spectra of native and recombinant alpha -chains. The recombinant alpha -chains have a lower ellipticity and a broader spectrum than the native alpha -chains.


Fig. 4. A, circular dichroism spectra of the carboxyl derivatives of human hemoglobin with alpha rHbA (solid line) and native HbA (dashed line). B, recombinant alpha -chain in the absence of beta -chain (solid line) and native alpha -chains (dashed line). Three spectra were repeated for each sample and then averaged. The protein concentration was 0.1 mg/ml in 0.05 M phosphate buffer, pH 7.0, at 15 °C.
[View Larger Version of this Image (16K GIF file)]


Nuclear Magnetic Resonance

Fig. 5 shows the downfield region of the NMR spectra of alpha rHbA and HbA in the deoxy form. The resonances between 15 and 24 ppm originate from protons in the heme groups and/or from protons in amino acid residues located in the heme pockets. These resonances are shifted downfield by the hyperfine interactions between the corresponding protons and the unpaired electrons of the iron atoms. In deoxy-HbA, the hyperfine shifted resonances at 22.2 and 18.9 ppm have been assigned to the beta -subunits, and those at 20.3 and 16.8 ppm have been assigned to the alpha -subunits (22-24). As shown in the figure, in deoxy-alpha rHbA the same hyperfine shifted resonances are observed, and their chemical shifts are, within experimental error, the same as in deoxy-HbA. The spectral region from 11 to 15 ppm in Fig. 5 contains several other hyperfine shifted resonances and four exchangeable proton resonances. The hyperfine shifted resonances are significantly broader than the exchangeable proton resonances (i.e. 350-500 versus 50-75 Hz). Due to these differences in the line widths and to the spectral overlap, only the exchangeable proton resonances in the spectral region 11-15 ppm in Fig. 5 can be observed accurately. In deoxy-HbA, these four exchangeable proton resonances have been assigned to specific hydrogen bonds in the Hb molecule as follows: the resonance at 14.1 ppm to the hydrogen bond between Tyralpha 42(C7) and Aspbeta 99(G1) at the alpha 1beta 2 interface (25, 26); the resonance at 13.0 ppm to the hydrogen bond between Aspalpha 126(H9) and Tyrbeta 35(C1) at the alpha 1beta 1 interface; the resonance 12.2 ppm to the hydrogen bond between Hisalpha 103(G10) and Asnbeta 108(G10) at the alpha 1beta 1 interface (26); and the resonance at 11.1 ppm to the hydrogen bond between Aspalpha 94(G1) and Trpbeta 37(C3) at the alpha 1beta 2 interface (27).3 As shown in the figure, in deoxy-alpha rHbA these four exchangeable proton resonances are very close if not identical to those in deoxy-HbA.


Fig. 5. Hyperfine shifted and exchangeable proton resonances of deoxy-HbA (lower spectrum) and deoxy-alpha rHbA (upper spectrum) in 0.1 M Bis-Tris buffer, pH 6.85, in 90% H2O, 10% D2O at 29 °C.
[View Larger Version of this Image (11K GIF file)]


Our NMR results for alpha rHbA in the ligated state are shown in Figs. 6 and 7. Fig. 6 shows the spectral region from 9.5-14.5 ppm. In carboxy-HbA, the resonances at 12.95, 12.1, and 10.2 ppm originate from exchangeable protons and have been assigned as follows: the resonance at 12.95 ppm to the hydrogen bond between Aspalpha 126(H9) and Tyrbeta 35(C1) at the alpha 1beta 1 interface (26); the resonance at 12.1 ppm to the hydrogen bond between Hisalpha 103(G10) and Asnbeta 108(G10) at the alpha 1beta 1 interface (26); and the resonance at 10.23 ppm to the hydrogen bond between Aspalpha 94(G1) and Asnbeta 102(G4) at the alpha 1beta 2 interface (25). In carboxy-alpha rHbA, these exchangeable proton resonances occur at the same spectral positions as those in carboxy-HbA.


Fig. 6. Exchangeable and heme proton resonances of carboxy-HbA (lower spectrum) and carboxy-alpha rHbA (upper spectrum) in 0.1 M Bis-Tris buffer, pH 6.85, in 90% H2O, 10% D2O at 29 °C.
[View Larger Version of this Image (9K GIF file)]



Fig. 7. Ring-current shifted proton resonances of carbonmonoxy HbA (lower spectrum) and carbonmonoxy alpha rHbA (upper spectrum) in 0.1 M Bis-Tris buffer, pH 6.85, in 90% H2O, 10% D2O at 29 °C.
[View Larger Version of this Image (8K GIF file)]


The spectra shown in Fig. 6 also contain several resonances from the heme groups. In carboxy-HbA these resonances are (28, 29): the resonance at 10.45 ppm (mesoproton gamma  of the heme in alpha -chains); the resonance at 10.1 ppm (mesoproton alpha  of the heme in the beta -chain); and the resonance at 9.7 ppm (mesoproton delta  of the hemes in alpha - and beta -chains and mesoproton alpha  of the heme in the alpha -chain). In carboxy-alpha rHbA, the latter two heme resonances occur at the same positions as in carboxy-HbA. However, the resonance of the mesoproton gamma  of the heme in alpha -chains (10.45 ppm) is missing from the spectrum.

Fig. 7 shows the region from -2.2 to -0.4 ppm of the NMR spectra of carboxy-alpha rHbA and HbA. This region contains resonances from protons in the heme groups and/or amino acids in the heme pockets that are shifted upfield by the ring-current effect of the heme groups. In carboxy-HbA, the resonance at -1.77 ppm has been assigned to the gamma 2-CH3 protons of the distal Val residues in the alpha - and beta -subunits, Valalpha 62(E11) and Valbeta 67(E11) (28). As shown in Fig. 7, the position of this resonance in carboxy-alpha rHbA is nearly identical to that in carboxy-HbA.

Functional Studies

The binding isotherms of HbA and alpha rHbA were measured using 1.5-2.0 mM heme, a concentration at which dimers and their associated complications are negligible. For these experiments, heme oxydation was below 5%, thus eliminating the need for adding the reducing system. The curves were analyzed according to the Adair equation (17) and yielded the thermodynamic parameters listed in Table II. Although these parameters do not differ significantly within the 66.7% confidence limit, the cooperativity of alpha rHbA is decreased at all oxygen fractional saturations as shown in Fig. 8.

Table II.

Comparison of the oxygen binding parameters recovered for HbA and alpha rHbA

Buffer, 50 mM HEPES, pH 7.4; temperature, 25 °C.
HbA  alpha rIIbA

K1 × 105 (mol-1) 1.5  ± 0.3 1.9  ± 0.3
K2 × 105 (mol-1) 0.9  ± 0.3 1.3  ± 0.2
K3 × 105 (mol-1) 2.5  ± 1.5 0.8  ± 0.4
K4 × 105 (mol-1) 33.0  ± 7.0 31.0  ± 6.0
 Delta Ga (kcal/mol)  -1.8  ± 0.3  -1.6  ± 0.2
Pmb (torr-1) 2.0  ± 0.3 2.4  ± 0.3
nmaxc 2.3 2.0

a  Cooperative free energy = -RT ln K4/K1.
b  Median ligand activity.
c  Hill parameter.


Fig. 8. Cooperativity of natural HbA (solid line) and recombinat HbA (dashed line) at increasing fractional saturation with oxygen. Measurements were done in 50 mM HEPES buffer, pH 7.4, at 25 °C.
[View Larger Version of this Image (15K GIF file)]


The oxygen binding parameters of HbA and alpha rHbA were measured in the presence of Cl- and 2,3-diphosphoglycerate. The data (Table III) indicate that the oxygen affinity and cooperativity of natural HbA and alpha rHbA are similarly affected by these effectors and that these exhibit the same Bohr effect.

Table III.

Oxygen equilibrium data were obtained using the thin layer dilution method of Dolman and Gill

The buffer was 50 mM Hepes, pH 7.4; protein concentration, 30 mg/ml; and temperature, 25 °C.
Pm nmax Bohr effect (Delta H+/Delta pH)

HbA (no NaCl) 2.0  ± 0.3 2.3
HbA (0.2 M NaCl) 4.51  ± 0.01 3.0
 Delta log Pm ± NaCl 0.35
HbA (0.01 M DPGa) 10.0  ± 0.1 3.1
 Delta log Pm ± DPG 0.7
HbA (0.1 M NaCl) 0.65 (pH = 7.4)
 alpha rHbA (no NaCl) 2.4  ± 0.3 2.0
 alpha rHbA (0.2 M NaCl) 5.85  ± 0.01 2.6
 Delta log Pm ± NaCl 0.39
 alpha rHbA (0.01 M DPG) 12.3  ± 0.1 2.6
 Delta log Pm ± DPG 0.7
 alpha rHbA (0.1 M NaCl) 0.65 (pH = 7.4)

a  DPG, 2,3-diphosphoglycerate.

CO Recombination Kinetics

The kinetics of CO binding to native HbA and alpha rHbA were measured (Fig. 9) and the data analyzed using a multiexponential model. Each binding curve was well represented by two components whose rates varied by about 30-fold (Table IV). The slower phase originated from CO binding to the tetramer, and the fast phase originated from CO binding to the dimer as described previously (30). Comparison of the rate constants shows that HbA and alpha rHbA exhibit similar rates of CO recombination for both dimers and tetramers.


Fig. 9. Kinetics of CO binding to HbA and alpha rHbA. Absorbance changes following flash photolysis of the heme-CO complex was followed at 436 nm using 5 µM heme and 50 µm CO at 23 °C in 0.1 M Bis-Tris, pH 7.0, containing 0.1 M KCl.
[View Larger Version of this Image (15K GIF file)]


Table IV.

Kinetic parameters, dimer-tetramer equilibrium constants, and dimer-tetramer assembly free energies for HbA and alpha rHbA

k1 and k2 are the bimolecular association rate constants for CO binding to tetramer and dimer, respectively. a1 and a2 are the absorbance parameters for tetramer and dimer, respectively. Ka is the dimer-tetramer association equilibrium constant calculated from the a1 and a2 values. Delta G is the dimer-tetramer assembly free energy calculated from the dimer-tetramer association equilibrium constant. Conditions: 0.1 M Bis-Tris and 0.1 M KCl, pH 7.0, 23 °C.
a1 k1 a2 k2 Ka  Delta G

×10-5 m-1 s-1 ×10-5 m-1 s-1 ×10-5 m-1 kcal/mol
HbA 0.081  ± 0.014 0.62  ± 0.14 0.104  ± 0.016 20.5  ± 3.8 2.93  ± 1.02  -7.34  ± 0.23
 alpha rHbA 0.063  ± 0.019 0.73  ± 0.13 0.105  ± 0.023 19.0  ± 2.5 2.00  ± 0.63  -7.12  ± 0.22

The kinetic analysis also yields absorbance values that reflect the amounts of tetramer and dimer. These values were used to calculate the dimer-tetramer association constant (Ka) and the accompanying Delta G value for this transition (Table IV). The resulting Ka values for HbA (2.93 × 105 M-1) and alpha rHbA (2.0 × 105 M-1) and their respective Delta G values (-7.34 and -7.12 kcal/mol) were similar.

The kinetics of CO binding to native and recombinant alpha -chains were also measured. Each binding curve was well represented by two components whose parameters are presented in Table V. The major components of the native and recombinant alpha -chains reacted at the same rate (k2 = 18.2 and 19.7 × 105 M-1 s-1, respectively). However, the two samples differed significantly in that the major component corresponded to virtually the entire (97%) native alpha -chain but to only 63% of the recombinant alpha -chain.

Table V.

Kinetic parameters for native and recombinant alpha -chains

k1 and k2 are the bimolecular association rate constants for CO binding to the two components of native and recombinant alpha -chains, and a1 and a2 are the corresponding absorbance parameters. Conditions: 0.1 M Bis-Tris and 0.1 M KCl, pH 7.0, 23 °C.
a1 k1 a2 k2

×10-5 m-1 s-1 ×10-5 m-1 s-1
Native alpha  chain 0.005  ± 0.001 2.35  ± 0.77 0.165  ± 0.005 18.2  ± 1.6
 alpha r chain 0.062  ± 0.014 8.21  ± 0.83 0.107  ± 0.010 19.7  ± 1.4


DISCUSSION

The long term objective of this work is elucidation of the role of alpha -chains on the structure and function of hemoglobin. Our strategy involved comparison of the expressed and native alpha -chains both as the isolated chain or incorporated into the HbA tetramer. Any observed differences in conformational or functional properties can then be attributed to the alpha -chain. Thus, although the alpha rHbA was almost identical to native HbA, the subtle differences that were observed provide new details on the role of proper alpha -chain folding in maintaining the structure and cooperativity of the hemoglobin molecule. The conformational and functional aspects will be considered separately.

Conformational Studies

The NMR spectra in Fig. 5 indicate that the overall conformation of the heme pockets in deoxy-alpha rHbA is similar to that in deoxy-HbA. A subtle difference, however, is observed for the relative intensities of the hyperfine shifted resonances at 22.2 and 16.8 ppm in alpha rHbA. In deoxy-HbA, the intensity of the alpha -chain hyperfine shifted resonance at 16.8 ppm is the same as that of the beta -chain hyperfine shifted resonance at 22.2 ppm (namely, six protons/heme) (31).4 In contrast, in deoxy-alpha rHbA the alpha -chain resonance at 16.8 ppm appears more intense than the beta -chain resonance at 22.2 ppm. In order to understand the origin of this difference we have measured the absolute intensity of the hyperfine shifted resonance of alpha rHbA using a reference standard (tris(6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionate) europium) complexed with t-butyl alcohol (31). The results showed that the beta -chain resonance at 22.2 ppm in alpha rHbA has the same intensity as the corresponding resonance in HbA. In contrast, the intensity of the alpha -chain resonance at 16.8 ppm in alpha rHbA is increased by a factor of approximately 2 relative to that in HbA. The origin of this difference is difficult to ascertain since, at present, it is not known whether the alpha -chain hyperfine shifted resonance at 16.8 ppm originates from protons in the heme groups, from protons in the amino acids in the heme pockets, or from both. Future NMR experiments on HbA molecules containing fully deuterated heme groups may provide an answer to this question.

Similarly, in carboxy-alpha rHbA (Fig. 6) the resonance of the mesoproton gamma  of the heme in the alpha -chain (10.45 ppm) is missing from the spectrum, probably shifted to a different spectral position in which it cannot be resolved. This result suggests that in the ligated form the heme environment in the alpha -subunits of alpha rHbA may also differ from that in HbA. Alterations in the heme pockets are also suggested by the ring-current shifted resonances (Fig. 7). All these resonances are broader in alpha rHbA than in native HbA, and in alpha rHbA the resonance at -0.64 ppm appears to be shifted from its position in HbA. Similar differences in the ring-current shifted resonances have been previously observed for a full recombinant HbA (4) and have been attributed to a different mode of heme insertion. One possibility previously suggested is the existence of two heme orientations that differ by a 180° rotation about the alpha ,gamma -mesoaxis of the porphyrin (32). Our results for alpha rHbA do not support this suggestion, since a rotation about the alpha ,gamma -mesoaxis would conserve the environment of the gamma -mesoproton. In contrast, our results show that in alpha rHbA the gamma -mesoproton resonance is shifted from its position in the spectrum of HbA (Fig. 6). Moreover, our results show that the position of the distal (E11)Val residues relative to the heme groups in ligated alpha rHbA is very close to that in HbA. This is consistent with the observed similarity of the CD spectra (Fig. 4A) and indicates that the small difference observed near 410 nm is not due to heme inversion. Further investigations are necessary in order to characterize fully the conformation of the alpha -chain heme pockets in alpha rHbA. Figs. 5 and 6 show that the exchangeable proton resonances of deoxy-alpha rHbA are very similar if not identical to those in HbA in both deoxy and carboxyl forms. These findings indicate that the hydrogen bonds at the alpha 1beta 2 and alpha 1beta 1 interfaces that can be monitored by NMR are identical in deoxy- and carboxy-alpha rHbA and HbA.

The Soret region of the CD spectrum primarily reflects the interaction of the heme chromophore with the surrounding aromatic residues (21). Thus, it serves as a sensitive probe of correct heme pocket refolding. In the heme pocket, in the absence of amino acid substitutions a decrease in ellipticity has been attributed to the presence of inverted heme (33). The CD spectra of HbA and alpha rHbA have a similar ellipticity (Fig. 4A), suggesting correct heme insertion. However, a small difference in the shape of the spectrum is observed near 410 nm, which suggests the presence of subtle conformational modifications. Although no direct correlation between the NMR and the CD spectra can be made, it is interesting to note that NMR data suggest the correct refolding of the heme pocket, the absence of inverted heme, and the presence of subtle modifications in the heme pocket resonaces.

The CD spectrum of alpha r-chains (Fig. 4B) is broader than that of native alpha -chains and has a decreased ellipticity, suggesting some heme disorder and heterogeneity. The absence of similar heterogeneity in the alpha rHbA suggests that optimal refolding of the alpha -heme pocket occurs upon the tetrameric assembly of the protein.

Functional Studies

The thermodynamic analysis reported in Table II shows that HbA and alpha rHbA exhibit oxygen binding properties that are indistinguishable except for a reduced cooperativity. Since the NMR data indicate identical resonances for residues at the alpha 1beta 1 and alpha 1beta 2 interfaces, the reduced cooperativity cannot be attributed to altered quaternary assembly. The free energy of cooperativity, Delta Gc, is the same for HbA and alpha rHbA (-1.8 ± 0.3 and -1.6 ± 0.2 kcal/heme). Thus, the decreased value of nmax measured for alpha rHbA is probably due to phenomena linked to the intermediate stages of oxygenation. At present the molecular events associated with the intermediates of oxygenation are still elusive, as these partially oxygenated forms are very unstable and their fractional distribution is much smaller than anticipated by a statistical distribution of ligands on tetrameric hemoglobin (34). These results suggest that substitution of the recombinant for the native alpha -globin is sufficient to alter these oxygenation intermediates independently of the quaternary assembly and propose a key role for nonquaternary interactions in the modulation of oxygen cooperativity.

The Bohr effect and the oxygen affinity regulation by allosteric effectors are sensitive probes of tertiary structure and quaternary assembly. In alpha rHbA the Bohr effect and the sensitivity to Cl- and 2,3-diphosphoglycerate are equivalent to that in native HbA (Table III). This indicates that the Bohr effect groups and the effector binding sites are correctly aligned in the half-recombinant protein. This is probably favored in the half-recombinant hemoglobin by the native partner chains, which help direct the correct refolding and reassembly of the recombinant chains (35).

The CO binding experiments confirm the oxygen equilibrium data (Fig. 9 and Table IV) and reveal that HbA and alpha rHbA are indistinguishable on the basis of two additional criteria: rate of CO binding and the energetics of dimer-tetramer association. Our observation that the major component of both recombinant and native alpha -chains exhibited the same rate (19.7 and 18.2 × 105 M-1 s-1) as that of the dimers of native HbA (20.5 × 105 M-1 s-1) and alpha rHbA (19.5 × 105 M-1 s-1) is consistent with a similar conformation of isolated alpha -chains, whether monomeric or polymeric, and the alpha -chains within a hemoglobin dimer. The differences observed between the binding kinetics of the expressed and native alpha -chains thus are eliminated during tetramer formation, as the energetics of quaternary assembly more than compensate for the decreased conformational flexibility of alpha r upon its incorporation into the tetramer.

In addition to characterizing HbA, it is also important to determine the properties of the isolated chains. The ability of isolated alpha -globin to refold with heme may perhaps be explained by the results from the CO binding kinetics and CD. The greater heterogeneity in CO binding kinetics of the alpha r-chain suggests a correspondingly greater degree of structural or dynamic heterogeneity relative to that of the native alpha -chain. This result is consistent with the CD measurements, which reflect the time-averaged structure of all alpha -chain components and which show reduced ellipticity and a broader spectrum in the Soret region for the alpha r-chains. Taken together, these approaches suggest the presence of alternating conformations for the isolated alpha r-chain. A dynamic access to a wide conformational space would enhance its prospects for correctly refolding with the heme and ultimately attaining a conformation suitable for pairing with beta -chain and formation of a functional HbA tetramer.


CONCLUSION

In conclusion, we have expressed alpha -globin that can refold with heme in the absence of the beta -chain. The isolated alpha -globin exhibits a wide range of conformational flexibility. Furthermore, this alpha -globin can recombine with the heme and assemble with beta -chain to produce a recombinant HbA whose functional and conformational characteristics resemble those of natural HbA. Although subtle modifications in the heme pocket and a decreased cooperativity are observed, the contacts across the alpha 1beta 1 and alpha 1beta 2 interfaces are retained. These findings underscore the key role played by the tertiary structure of the heme region, exclusive of the quaternary structure, in modulating the functionality of the HbA molecule. Our results also suggest a key role for nonquaternary interactions in processes involving the relatively unstable oxygenation intermediates. The expressed alpha -globin is thus suitable for construction of mutants to be used in future studies of HbA structure-function relationships.


FOOTNOTES

*   This work was supported by United States Public Health Service Grant PO1-HL48517. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Present address: Istituto di Chimica Biologica, Universita di Cagliari, Italy.
Dagger Dagger    To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Maryland, Medical School, 108 N. Greene St., Baltimore, MD 21201. Tel.: 410-706-7672; Fax: 410-706-7390; E-mail: cfrontic{at}umabnet.ab.umd.edu.
1    The abbreviations used are: HbA, human normal adult hemoglobin; alpha r, recombinant alpha -chains; alpha rHbA, human hemoglobin with recombinant alpha -chain; beta rHbA, human hemoglobin with recombinant beta -chain; Bis-Tris, [bis(2-hydroxyethyl)-amino]tris(hydroxymethyl)methane; HPLC,high performance liquid chromatography; TPCK, L-1-tosylamido-2-phenylethyl chloromethyl ketone; FXa, activated Factor X.
2    In earlier NMR investigations of hemoglobin, proton chemical shifts have been referenced to the signal of water in each sample that is 4.73 ppm downfield from that of 2,2-dimethyl-2-silapentane-5-sulfonate at 29 °C. For a detailed presentation of the conversion of the chemical shift scale in NMR spectra of hemoglobin, see Ho (22).
3    The assignment of this resonance is currently tentative. For a detailed discussion of the possible origin of this resonance, see Ho (22).
4    The NMR spectra shown in Fig. 5 have been obtained using the jump-and-return pulse sequence with maximum excitation at the alpha -chain hyperfine shifted resonance at 16.8 ppm. Due to the frequency-dependent excitation profile of the pulse sequence used, the intensity of the beta -chain hyperfine shifted resonance at 22.2 ppm shown in the figure corresponds to 75% of its actual value.

Acknowledgements

We thank Dr. Walter Kisiel for the gift of Factor X and Daniel Youch for assistance in the construction of pNFalpha .


REFERENCES

  1. Vandegriff, K. D. (1992) Biotechnol Genet Eng 10, 403-453 [Medline] [Order article via Infotrieve]
  2. Hoffman, S. J., Looker, D. L., Roehrich, J. M., Cozart, P. E., Durfee, S. L., Tedesco, J. L., and Stetler, G. L. (1990) Proc. Natl. Acad. Sci. U. S. A. 8, 8521-8525
  3. Hernan, R. A., and Sligar, S. G. (1996) J. Biol. Chem. 270, 26257-26264 [Abstract/Free Full Text]
  4. Shen, T.-J., Ho, N. T., Simplaceanu, V., Zou, M., Green, B. N., Tam, M. F., and Ho, C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8108-8112 [Abstract/Free Full Text]
  5. Nagai, K., and Thogersen, H. C. (1984) Nature 309, 810-813 [Medline] [Order article via Infotrieve]
  6. Fronticelli, C., O'Donnell, J. K., and Brinigar, W. S. (1991) J. Protein Chem. 10, 495-501 [Medline] [Order article via Infotrieve]
  7. Tame, J., Shih, D. T.-b., Pagnier, J., Fermi, G., and Nagai, K. (1991) J. Mol. Biol. 218, 761-767 [CrossRef][Medline] [Order article via Infotrieve]
  8. Michelson, A. M., Markam, A. F., and Orkin, S. H. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 472-476 [Abstract]
  9. Mott, J. E., Grant, R. A., Ho, Y.-S., and Platt, T. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 88-92 [Abstract]
  10. Bucci, E., and Fronticelli, C. (1965) J. Biol. Chem. 240, PC551-PC552 [Free Full Text]
  11. Biochemistry 8, 1848-1854Geraci, G., and Li, T.-K. Biochemistry 8, 1848-1854
  12. Rossi Fanelli, M. R., Amiconi, G., and Antonini, E. (1978) Eur. J. Biochem. 92, 253-259 [Abstract]
  13. Chiancone, E., Fronticelli, C., Gattoni, M., Urbaitis, B. K., and Bucci, E. (1992) J. Chromatogr. 604, 117-123 [CrossRef][Medline] [Order article via Infotrieve]
  14. Shelton, J. B., Shelton, J. R., and Schroeder, W. A. (1981) J. Liq. Chromatogr. 4, 1381-1392
  15. Bucci, E., Fronticelli, C., Gryczynski, Z., Razynska, A., and Collins, J. H. (1993) Biochemistry 32, 3519-3626 [Medline] [Order article via Infotrieve]
  16. Dolman, D., and Gill, S. J. (1978) Anal. Biochem. 87, 127-134 [Medline] [Order article via Infotrieve]
  17. Adair, G. S. (1925) J. Biol. Chem. 63, 529-545 [Free Full Text]
  18. Wyman, J., and Gill, S. J. (1990) Binding and Linkage, University Science Books, Mill Valley, CA
  19. Markowitz, A., Robinson, R. C., Omata, Y., and Friedman, F. K. (1992) Anal. Instrum. 20, 213-221
  20. Plateau, P., and Gueron, M. (1982) J. Am. Chem. Soc. 104, 7310-7311
  21. Hsu, M.-C., and Woody, R. W. (1971) J. Am. Chem. Soc. 93, 3515-3525 [Medline] [Order article via Infotrieve]
  22. Ho, C. (1992) Adv. Protein Chem. 43, 153-312 [Medline] [Order article via Infotrieve]
  23. Linstrom, T. R., Ho, C., and Pisciotta, A. V. (1972) Nature New Biol. 237, 263-264 [Medline] [Order article via Infotrieve]
  24. Takahashi, S., Lin, A. K.-L. C., and Ho, C. (1980) Biochemistry 19, 5196-5202 [Medline] [Order article via Infotrieve]
  25. Fung, L. W.-M., and Ho, C. (1975) Biochemistry 14, 2526-2535 [Medline] [Order article via Infotrieve]
  26. Russu, I. M., Ho, N. T., and Ho, C. (1987) Biochim. Biophys. Acta 914, 40-48 [Medline] [Order article via Infotrieve]
  27. Ishimori, K., Imai, K., Miyazaki, G., Kitagawa, T., Wada, Y., and Morimoto, I. (1992) Biochemistry 31, 3256-3264 [Medline] [Order article via Infotrieve]
  28. Dalvit, C., and Ho, C. (1985) Biochemistry 24, 3398-3407 [Medline] [Order article via Infotrieve]
  29. Craescu, C. T., and Mispelter, J. (1989) Eur. J. Biochem. 181, 87-96 [Abstract]
  30. Doyle, M. L., Lew, G., De Young, A., Kwiatkowski, L., Wierzba, A., Noble, R. W., and Ackers, G. K. (1992) Biochemistry 31, 8629-8639 [Medline] [Order article via Infotrieve]
  31. Ho, C., Lam, C. H. J., Takahashi, S., and Viggiano, G. (1982) in Hemoglobin and Oxygen Binding (Ho, C., ed), pp. 141-149, Elsevier Biomedical, New York
  32. La Mar, G. R., Davis, N. L., Parish, D. W., and Smith, K. M. (1983) J. Mol. Biol. 168, 887-896 [Medline] [Order article via Infotrieve]
  33. Aojula, H. S., Wilson, M. T., and Drake, A. (1986) Biochem. J. 237, 613-616 [Medline] [Order article via Infotrieve]
  34. Di Cera, E., Charles, H. R., and Gill, S. J. (1987) Biochemistry 26, 4003-4008 [Medline] [Order article via Infotrieve]
  35. Yip, Y. K., Waks, M., and Beychok, S. (1972) J. Biol. Chem. 247, 7237-7244 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.